Angiotensinogen gene polymorphism, again?

Journal of Hypertension

Volumn 21, Issue 10, 2003, Pages 1815-1818

  Cusi, Daniele ^a   Macciardi, Fabio ^a,b   Barlassina, Cristina ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; GENE PRODUCT;

ANGIOTENSINOGEN GENE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DNA FLANKING REGION; DNA POLYMORPHISM; EDITORIAL; ETHNIC GROUP; EXON; GENE; GENE FUNCTION; GENE STRUCTURE; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; HYPERTENSION; INTRON; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0142010518     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200310000-00004     Document Type: Editorial

References (30)

1. Marshall E. Snipping away at genome patenting. Science 1997; 19:1752-1753.
2. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nature Genet 1999; 22:239-247.
3. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al., for the International SNP Map Working Group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409:928-933.
4. Cartegni L, Chew S, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Rev Genet 2002; 3:285-298.
5. Luft FC. Molecular genetics of human hypertension. J Hypertens 1998; 16:1871-1878.
6. Bianchi G, Cusi D. Association and linkage analysis of alpha-adducin polymorphism: is the glass half full or half empty? Am J Hypertens 2000; 13:739-743.
7. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 2:169-180.
8. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30:1331-1337.
9. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17:9-17.
10. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23:1269-1275.
11. Wu X, Luke A, Rieder M, Lee K, Toth EJ, Nickerson D, et al. An association study of angiotensinogen polymorphism with serum level and hypertension in an African American population. J Hypertens 2003; 21:1847-1852.
12. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797.
13. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, et al. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 1997; 30:1325-1330.
14. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 1999; 33:108-1 15.
15. Yanai K, Nibu Y, Murakami K, Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem 1996; 271:15981-15986.
16. Ishikawa K, Baba S, Katsuya T, Iwai N, Asai T, Fukuda M, et al. T + 31C polymorphism of angiotensinogen gene and essential hypertension. Hypertension 2001; 37:281-285.
17. Ishigami T, Tamura K, Fujita T, Kobayashi I, Hibi K, Kihara M, et al. Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I. Hypertension 1999; 34:430-434.
18. Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, Brown CD, et al. Angiotensinogen Gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 2002; 277:36889-36896.
19. Jeunemaitre X, lnoue I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60:1448-1460.
20. Clark AG. Inference of haplotypes from PCR-amplified samples of diploid populations. Mol Biol Evol 1990; 7:111-122.
21. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12:921-927.
22. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
23. Qian D, Beckmann L. Minimum-recombinant haplotyping in pedigrees. Am J Hum Genet 2002; 70:1434-1445.
24. Goldstein DB. Islands of linkage disequilibrium. Nature Genet 2001; 29:109-111.
25. Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nature Rev Genet 2003; 4:587-597.
26. Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, et al. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 2003; 13:173-181.
27. Brand E, Chatelain N, Paillard F, Tiret L, Visvikis S, Lathrop M, et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Eur J Hum Genet 2002; 10:715-723.
28. Tost J, Brandt O, Boussicault F, Derbala D, Caloustian C, Lechner D, Gut IG. Molecular haplotyping at high throughput. Nucleic Acids Res 2002; 1:1-8.
29. Mennella T. The out-of-hand omnipresent ome. Please let's avoid further perversion of the ome. The Scientist 2003; 17:52.
30. Freimer N, Sabatti C. The human phenome project. Nature Genet 2003; 34:15-21.